Innovent Biologics mazdutide can pave way for transformative T2D treatment: GlobalData
Mazdutide will be the second drug from Innovent Biologics in Chinese metabolic disorders market
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
clinical trail
New data for Roche’s Ocrevus show benefit in disability progression and cognitive decline in…
The treatment with Ocrevus resulted in a majority of patients experiencing no disease progression in a one-year analysis of…
Valneva says Chikungunya vaccine phase-III trial has met primary endpoint
In August, after Valneva gave a positive update on the phase-III trial